Ivermectin in COVID-19 Patients a Multicenter: Retrospective Study
*Corresponding Author:
Copyright: © 2021 . This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Abstract
During 2020, many Medical Centers and solo Practitioners have adopted the I.D.E.A. protocol (Ivermectin, Dexamethasone, Enoxaparin and Aspirin) as the only inexpensive, effective, safe means to fight COVID infection. We hereby summarize the experience of some of these endeavors, stressing the fact that -by providing their patients with this protocol they have saved thousands of lives that, if not, would have been put in an unnecessary danger, or simple lost. We take into consideration the percentage of COVID+ patients that required ulterior admittance, and also the death rate amid those admitted.